Staritas Asia Pacific

Call Directions Website

Staritas Asia Pacific Make every choice clear. For more than 50 years, ECRI is recognized for its unwavering dedication to transparency and strict conflict-of-interest policies.

The organization has earned a reputation as the trusted voice of unbiased, research-based assurance for tens of thousands of members globally using its solutions into risk management and patient care. ECRI consists of its medical device testing labs located in North America and the Asia Pacific with bio-engineers conducting hands-on independent device testing for safety and human factors usability. ECRI is designated an Evidence-based Practice Center by the U.S. Agency for Healthcare Research and Quality. ECRI Institute PSO is listed as a federally certified Patient Safety Organization by the U.S. Department of Health and Human Services.

๐Ÿšจ The next healthcare supply disruption wonโ€™t look like the last one. A facility fire. A product recall. A manufacturing...
14/09/2026

๐Ÿšจ The next healthcare supply disruption wonโ€™t look like the last one.

A facility fire. A product recall. A manufacturing delay. A natural disaster. A geopolitical event. The cause may be impossible to predictโ€”but your response doesnโ€™t have to be. ๐Ÿฅ

Healthcare organizations can build resilience before disruption strikes by:
โœ… Establishing clear contingency plans
๐Ÿ”Ž Identifying clinically appropriate alternatives in advance
๐Ÿ“Š Using reliable intelligence to support confident decisions
โšก Equipping teams to respond quickly when availability changes

Because when patient care is at stake, the middle of a disruption is not the time to begin searching for answers. ๐Ÿ’ญ

With evidence-based functional equivalents covering more than 450,000 medical devices and capital equipment, Staritas helps healthcare organizations evaluate trusted alternatives, maintain continuity, and prepare for the unexpected. ๐Ÿ’ก

โ“Is your organization prepared for a disruption it hasnโ€™t encountered before?

๐Ÿ’ป Read our latest blog to learn more: https://staritas.com/blog/the-next-supply-disruption-wont-look-like-the-last-one/?utm_content=385602128&utm_medium=social&utm_source=linkedin&hss_channel=lcp-112333022

Disruptions are unpredictable. Preparation doesnโ€™t have to be. ๐Ÿ’ซ

๐—ง๐—ต๐—ฒ ๐—บ๐—ฒ๐—ฑ๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฑ๐—ฒ๐˜ƒ๐—ถ๐—ฐ๐—ฒ๐˜€ ๐˜€๐—ต๐—ฎ๐—ฝ๐—ถ๐—ป๐—ด ๐—ต๐—ฒ๐—ฎ๐—น๐˜๐—ต๐—ฐ๐—ฎ๐—ฟ๐—ฒ ๐˜๐—ผ๐—บ๐—ผ๐—ฟ๐—ฟ๐—ผ๐˜„ ๐—ฎ๐—ฟ๐—ฒ ๐—ฏ๐—ฒ๐—ถ๐—ป๐—ด ๐—ฑ๐—ฒ๐˜€๐—ถ๐—ด๐—ป๐—ฒ๐—ฑ ๐˜๐—ผ๐—ฑ๐—ฎ๐˜†. ๐—”๐—ฟ๐—ฒ ๐˜†๐—ผ๐˜‚ ๐—ฝ๐—ฎ๐—ฟ๐˜ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐—ฐ๐—ผ๐—ป๐˜ƒ๐—ฒ๐—ฟ๐˜€๐—ฎ๐˜๐—ถ๐—ผ๐—ป?We're thrille...
13/08/2026

๐—ง๐—ต๐—ฒ ๐—บ๐—ฒ๐—ฑ๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฑ๐—ฒ๐˜ƒ๐—ถ๐—ฐ๐—ฒ๐˜€ ๐˜€๐—ต๐—ฎ๐—ฝ๐—ถ๐—ป๐—ด ๐—ต๐—ฒ๐—ฎ๐—น๐˜๐—ต๐—ฐ๐—ฎ๐—ฟ๐—ฒ ๐˜๐—ผ๐—บ๐—ผ๐—ฟ๐—ฟ๐—ผ๐˜„ ๐—ฎ๐—ฟ๐—ฒ ๐—ฏ๐—ฒ๐—ถ๐—ป๐—ด ๐—ฑ๐—ฒ๐˜€๐—ถ๐—ด๐—ป๐—ฒ๐—ฑ ๐˜๐—ผ๐—ฑ๐—ฎ๐˜†. ๐—”๐—ฟ๐—ฒ ๐˜†๐—ผ๐˜‚ ๐—ฝ๐—ฎ๐—ฟ๐˜ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐—ฐ๐—ผ๐—ป๐˜ƒ๐—ฒ๐—ฟ๐˜€๐—ฎ๐˜๐—ถ๐—ผ๐—ป?

We're thrilled to announce that we will be speaking at IMDEC 2026!

๐ŸŽค Topic: Future-proofing Digital Technology in Medical Devices
๐Ÿ“… Date: Thursday, 27 August 2026
โฐ Time: 10:10 AM

If you're building the healthcare facility of the future, this session is for you. Eric Woo, Vice President of Staritas International, will unpack the key planning factors and critical considerations that separate reactive technology decisions from future-ready ones.

A heartfelt thank you to Medical Device Authority - MDA for the kind invitation โ€“ we're honored to be part of IMDEC again this year.

We look forward to seeing you there!

๐—ฃ๐—ฟ๐—ผ๐—ฐ๐˜‚๐—ฟ๐—ฒ๐—บ๐—ฒ๐—ป๐˜ ๐˜‚๐—ป๐—ฑ๐—ฒ๐—ฟ ๐—ฝ๐—ฟ๐—ฒ๐˜€๐˜€๐˜‚๐—ฟ๐—ฒ - ๐˜„๐—ต๐—ฎ๐˜ ๐—ฑ๐—ผ๐—ฒ๐˜€ ๐—ถ๐˜ ๐—ฟ๐—ฒ๐—ฎ๐—น๐—น๐˜† ๐—บ๐—ฒ๐—ฎ๐—ป ๐—ณ๐—ผ๐—ฟ ๐—ต๐—ฒ๐—ฎ๐—น๐˜๐—ต๐—ฐ๐—ฎ๐—ฟ๐—ฒ?Last week, our Vice President Eric Woo took the sta...
04/08/2026

๐—ฃ๐—ฟ๐—ผ๐—ฐ๐˜‚๐—ฟ๐—ฒ๐—บ๐—ฒ๐—ป๐˜ ๐˜‚๐—ป๐—ฑ๐—ฒ๐—ฟ ๐—ฝ๐—ฟ๐—ฒ๐˜€๐˜€๐˜‚๐—ฟ๐—ฒ - ๐˜„๐—ต๐—ฎ๐˜ ๐—ฑ๐—ผ๐—ฒ๐˜€ ๐—ถ๐˜ ๐—ฟ๐—ฒ๐—ฎ๐—น๐—น๐˜† ๐—บ๐—ฒ๐—ฎ๐—ป ๐—ณ๐—ผ๐—ฟ ๐—ต๐—ฒ๐—ฎ๐—น๐˜๐—ต๐—ฐ๐—ฎ๐—ฟ๐—ฒ?

Last week, our Vice President Eric Woo took the stage at the Association of Private Hospitals of Malaysia for the panel "Procurement Under Pressure: Efficiency, Smart Management and the Future of Healthcare Supply Chains โ€“ Enabler or Obstacle?"

A shift he highlighted: procurement decisions are no longer just about buying what a clinician specifies, or defaulting to the cheapest option. Increasingly, it's about making informed, evidence-based choices that hold up under real-world pressure.

That's exactly where functional equivalence comes in. At Staritas International, our Functional Equivalents solution covers more than 450,000 medical devices and capital equipment across 400+ product categories โ€” so when your supply chain is disrupted, you have safe, vetted alternatives ready, not guesswork.

Thank you to Dato Dr Jacob Thomas for moderating, and we are glad to have shared the stage with Dato Dr Adzuan Abdul Rahman and Li Xian Xin.

๐—ฃ๐—ฟ๐—ผ๐—ฐ๐˜‚๐—ฟ๐—ฒ๐—บ๐—ฒ๐—ป๐˜ ๐˜‚๐—ป๐—ฑ๐—ฒ๐—ฟ ๐—ฝ๐—ฟ๐—ฒ๐˜€๐˜€๐˜‚๐—ฟ๐—ฒ โ€” ๐˜„๐—ต๐—ฎ๐˜ ๐—ฑ๐—ผ๐—ฒ๐˜€ ๐—ถ๐˜ ๐—ฟ๐—ฒ๐—ฎ๐—น๐—น๐˜† ๐—บ๐—ฒ๐—ฎ๐—ป ๐—ณ๐—ผ๐—ฟ ๐—ต๐—ฒ๐—ฎ๐—น๐˜๐—ต๐—ฐ๐—ฎ๐—ฟ๐—ฒ?Last week, our Vice President Eric Woo took the sta...
04/08/2026

๐—ฃ๐—ฟ๐—ผ๐—ฐ๐˜‚๐—ฟ๐—ฒ๐—บ๐—ฒ๐—ป๐˜ ๐˜‚๐—ป๐—ฑ๐—ฒ๐—ฟ ๐—ฝ๐—ฟ๐—ฒ๐˜€๐˜€๐˜‚๐—ฟ๐—ฒ โ€” ๐˜„๐—ต๐—ฎ๐˜ ๐—ฑ๐—ผ๐—ฒ๐˜€ ๐—ถ๐˜ ๐—ฟ๐—ฒ๐—ฎ๐—น๐—น๐˜† ๐—บ๐—ฒ๐—ฎ๐—ป ๐—ณ๐—ผ๐—ฟ ๐—ต๐—ฒ๐—ฎ๐—น๐˜๐—ต๐—ฐ๐—ฎ๐—ฟ๐—ฒ?

Last week, our Vice President Eric Woo took the stage at the Association of Private Hospitals of Malaysia for the panel "Procurement Under Pressure: Efficiency, Smart Management and the Future of Healthcare Supply Chains โ€“ Enabler or Obstacle?"

A shift he highlighted: procurement decisions are no longer just about buying what a clinician specifies, or defaulting to the cheapest option. Increasingly, it's about making informed, evidence-based choices that hold up under real-world pressure.

That's exactly where functional equivalence comes in. At Staritas International, our Functional Equivalents solution covers more than 450,000 medical devices and capital equipment across 400+ product categories โ€” so when your supply chain is disrupted, you have safe, vetted alternatives ready, not guesswork.

Thank you to Dato Dr Jacob Thomas for moderating, and we are glad to have shared the stage with Dato Dr Adzuan Abdul Rahman and Li Xian Xin.

Big things are happening at Staritas International. ๐Ÿš€ Our COO Stuart Morris-Hipkins flew in from the US to meet the Asia...
26/06/2026

Big things are happening at Staritas International. ๐Ÿš€

Our COO Stuart Morris-Hipkins flew in from the US to meet the Asia Pacific team here in Kuala Lumpur; and it was a great opportunity to align, share updates, and get everyone excited about what's ahead.

Staritas may be a new name, but the foundation we stand on is anything but new. We carry forward years of trusted, neutral, and independent insights - and we're only getting started on making that even better.

Are you excited for what's ahead? Because we are. Stay tuned. โœจ

๐Ÿ’ฐ Every capital request comes with a compelling case.โžก๏ธ Aging equipment. New technology. Competitive pressure. Clinical ...
18/06/2026

๐Ÿ’ฐ Every capital request comes with a compelling case.

โžก๏ธ Aging equipment. New technology. Competitive pressure. Clinical preferences.

But one of the most common capital planning mistakes isn't choosing the wrong assetโ€”it's confusing need with want.

Too often, capital decisions are influenced by urgency, anecdotal evidence, or the loudest stakeholder in the room. The result?

๐Ÿ“‰ Resources are allocated based on perception rather than organizational risk and strategic value.

The strongest capital plans answer three critical questions:
โœ… Does this investment address a verified operational, clinical, regulatory, or financial risk?
โœ… Does it support the organization's strategic objectives?
โœ… Is the decision backed by objective asset, utilization, and performance data?

When capital planning is grounded in data rather than assumptions, organizations can:
๐Ÿ”น Prioritize investments based on risk and impact
๐Ÿ”น Improve capital allocation decisions
๐Ÿ”น Reduce avoidable spending
๐Ÿ”น Align stakeholders around a common source of truth

The challenge isn't determining what organizations want to replace. ๐ŸŽฏ The challenge is identifying what they need to replaceโ€”and when.

That's where connected asset intelligence and objective decision support become critical.

Read the full blog here: https://staritas.com/2026/05/14/the-most-common-capital-planning-mistake-confusing-need-vs-want/?utm_content=379997499&utm_medium=social&utm_source=linkedin&hss_channel=lcp-112333022

A CT scanner failure is never just an equipment issue.For HTM teams, one unexpected downtime event can quickly ripple ac...
25/05/2026

A CT scanner failure is never just an equipment issue.

For HTM teams, one unexpected downtime event can quickly ripple across an entire healthcare organization โ€” impacting emergency care, delaying diagnoses, disrupting patient flow, and creating operational strain at critical moments. โš ๏ธ๐Ÿฅ

As hospitals manage aging imaging fleets, tighter budgets, and increasing demand, replacement planning has become far more complex than simply tracking equipment age.

In our latest blog, we explore:

๐Ÿ”น Why a single CT scanner failure can impact the entire hospital
๐Ÿ”น Why age alone does not tell the full story
๐Ÿ”น How healthcare organizations can better assess operational & clinical risk
๐Ÿ”น Why proactive planning is becoming essential for resilience & continuity of care

๐Ÿ“– Read our full blog here: https://staritas.com/2026/05/21/when-one-ct-scanner-failure-can-disrupt-an-entire-hospital/

๐—ช๐—ต๐˜† ๐—ฑ๐—ผ ๐˜€๐˜๐—ฟ๐—ผ๐—ป๐—ด ๐—ต๐—ฒ๐—ฎ๐—น๐˜๐—ต๐—ฐ๐—ฎ๐—ฟ๐—ฒ ๐—ฝ๐—ฟ๐—ผ๐—ฑ๐˜‚๐—ฐ๐˜๐˜€ ๐˜€๐˜๐—ถ๐—น๐—น ๐—น๐—ผ๐˜€๐—ฒ ๐—บ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐˜€๐—ต๐—ฎ๐—ฟ๐—ฒ?Because todayโ€™s market doesnโ€™t reward products in isolation - ...
18/05/2026

๐—ช๐—ต๐˜† ๐—ฑ๐—ผ ๐˜€๐˜๐—ฟ๐—ผ๐—ป๐—ด ๐—ต๐—ฒ๐—ฎ๐—น๐˜๐—ต๐—ฐ๐—ฎ๐—ฟ๐—ฒ ๐—ฝ๐—ฟ๐—ผ๐—ฑ๐˜‚๐—ฐ๐˜๐˜€ ๐˜€๐˜๐—ถ๐—น๐—น ๐—น๐—ผ๐˜€๐—ฒ ๐—บ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐˜€๐—ต๐—ฎ๐—ฟ๐—ฒ?

Because todayโ€™s market doesnโ€™t reward products in isolation - it rewards products that are competitively positioned, actively managed, and understood in context.

Healthcare manufacturers are facing:
โ€ข Unexpected share loss
โ€ข Increased pricing pressure
โ€ข Utilization variability
โ€ข Competitive shifts that are often invisible until itโ€™s too late

The organizations outperforming the market are doing something differently:
โœ”๏ธ Tracking share movement at a granular level
โœ”๏ธ Benchmarking pricing against real market dynamics
โœ”๏ธ Identifying utilization leakage within accounts
โœ”๏ธ Acting on demand signals earlier

The question is no longer whether a product is better.

The question is whether itโ€™s winning in the market โ€” and whether you understand why.

Read the full blog:
https://linktr.ee/staritas_apac

Explore how Staritas helps manufacturers identify where theyโ€™re gaining or losing share - and whatโ€™s driving it.

Back on-site at Rumah Sakit Jantung dan Pembuluh Darah Harapan Kita (RSJPD HK) with Balai Pengamanan Alat dan Fasilitas ...
11/05/2026

Back on-site at Rumah Sakit Jantung dan Pembuluh Darah Harapan Kita (RSJPD HK) with Balai Pengamanan Alat dan Fasilitas Kesehatan (BPAFK) Jakarta as the team gears up for the final Biomedical Engineering Certification (BMEC) audit.

One thing this project has reinforced for us: a strong biomedical engineering department quietly shapes so much of patient safety behind the scenes. From asset management and maintenance processes to risk management and documentation standards, the work happening in BME really impacts the reliability of care delivery every single day.

Itโ€™s been great seeing the amount of effort and ownership the team has put into this journey over the past few months. Especially for a hospital recognized as one of Indonesiaโ€™s leading cardiac and vascular centers, the commitment to strengthening systems and processes has been incredibly encouraging to witness firsthand.

Excited for the final stretch - and excited to see more hospitals in the region investing in stronger healthcare technology management practices too.

Wearing Staritas Asia Pacific today and looking ahead to where healthcare is going. Organizations are prioritizing resil...
24/04/2026

Wearing Staritas Asia Pacific today and looking ahead to where healthcare is going. Organizations are prioritizing resilience, smarter resource allocation, and long-term sustainability, and supply chain strategy sits at the center of that transformation. The opportunity to support leaders with the insights they need to plan, adapt, and lead with confidence is what makes this work so impactful. Proud to be part of whatโ€™s ahead.

Address

West Wing, Level 12, Wisma Consplant 2, No. 7, Jalan SS16/1
Subang Jaya
47500

Opening Hours

Monday 08:00 - 16:30
Tuesday 08:00 - 16:30
Wednesday 08:00 - 16:30
Thursday 08:00 - 16:30
Friday 08:00 - 16:30

Telephone

+60356515500

Alerts

Be the first to know and let us send you an email when Staritas Asia Pacific posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share